Abstract:Objective To evaluate the toxicity and efficacy of three-dimensional conformal radiotherapy(3D-CRT) combined with oxaliplatin on inoperable stage Ⅲ non-small cell lung cancer(NSCLC) patients.Methods Sixty-four inoperable NSCLC patients were divided into induction chemotherapy followed by concurrent weekly low-dose oxaliplatin and radiotherapy group(group A) or sequential chemoradiotherapy group(group B).The group A were treated with inductive cisplatin(70mg/m2 d1-d3) basement chemotherapy(combined with vinorelbine 25mg/m2 d1,d8 or pacilitaxel 175mg/m2 d1 or gemcitabine 1000mg/m2 d1,d8 or docetaxel 75mg/m2 d1) for two cycles(21 days was a cycle) and followed by concurrent chemoradiotherapy(oxaliplatin 50mg weekly for 7 weeks).The following consolidation chemotherapy was consisted of two cycles of docetaxel(75mg/m2 d1) or gemcitabine(1000mg/m2 d1).The group B were treated with the same inductive chemotherapy for two cycles(42 days);the following procedures of the therapy were same also with group A except oxaliplatin.All patients were received with the same radiotherapy(66 Gy at 2Gy per fraction,five fractions per week in both two groups).The patients were followed-up on one month,three months.Results The median follow-up time was 13.5 months(range 2-39 months).The median overall survival(OS) time was 17.0 months in group A and 14.5 months in group B.The progression free survival(PFS) time was 12.9 months in group A and 9.2 months in group B.The 1-,2-year overall survival rates were 62.5%,56.3% and 28.1%,21.9%,respectively.The 1-and 2-year progression free survival(PFS) rates were 40.6%,31.3% and 15.6%,12.5%,respectively.The major treatment related toxicities included radiation-induced esophagitis,radiation pneumonitis,and haematological toxicities.None of them were observed grade 4 either radiation-induced pneumonitis or esophagitis.The incidence rate of grade 3 to 4 neutropenia was 28%(group A) and 15.6%(group B) respectively(P>0.05).The rate of grade 2 to 3 esophagitis was 37.5% and 12.5%,respectively(P<0.05).There was no death due to the treatment.Conclusion It is safe and efficient that the combination treatment of schedule of 3D-CRT combined with concurrent weekly low-dose oxaliplatin for inoperable stage Ⅲ NSCLC patient,and the therapeutic effects is tended to be superior to sequential demonstration.

Clinical Study of Treating Locally Advanced Non-squamous Cell Lung Cancer in the Old Patients Using Conformal Irradiation Combined with Pemetrexed

Long-Term Treatment Outcomes of the Elder Patients with Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma with Definitive Chemoradiotherapy or Radiotherapy.

Clinical Study of Treatment of Locally Advanced Non-Small Cell Lung Cancer by Intensity Modulated Irradiation Combined with Pemetrexed and Cisplatin

Study of Three-Dimensional Conformal Radiotherapy Combined with Concurrent Pemetrexed Chemotherapy and Erlotinib Maintenance in Treatment of Non-Squamous Cell Carcinoma of Locally Advanced Lung Cancer

Clinical Study of Three-Dimensional Conformal Radiotherapy Combined with Concurrent and Sequential Gemcitabine Chemotherapy for Stage Ⅲ Non-Small Cell Lung Cancer in Elderly Patients

P2-325: Chemotherapy in elderly (Over 75 years old)lung cancer patients: a retrospective analysis

Chemotherapy in elderly (Over 75 years old)lung cancer patients: a retrospective analysis: P2-325

Three Dimensional-conformal Radiotherapy Combined Concurrent Chemotherapy with Vinorelbine and Cisplatin for Stage Ⅲ Non-small Cell Lung Cancer

Concomitant Pemetrexed/Carboplatin Chemotherapy with 3-D Conformal Radiotherapy Followed by Pemetrexed/Carboplatin Consolidation Chemotherapy in Locally Advanced Non-Small Cell Lung Cancer in A Chinese Population

Clinical Study on the Effect of Hypofractionated Three -Dimensional Conformal Radiation Therapy in the Treatment of Non -Small Cell Lung Cancer

Effective Analysis of Three-Dimensional Conformal Radiotherapy Plus Chemotherapy for Treating Elderly Non-Small-cell Lung Cancer

Three dimensional-conformal radiotherapy combined with gemcitabine chemotherapy for locally advanced non-small cell lung cancer

Clinical Study of Combined Chemotherapy Containing Carboplatin in the Treatment of Aged Patients with Advanced Non-Small Cell Lung Cancer(nsclc)

Short-term Efficacy of Three-dimensional Conformal Radiotherapy Combined with Chemotherapy in the Treatment of Local Recurrence in Advanced Non-small Cell Lung Cancer

Clinical Study on Accurate Radiotherapy Combined with Chemotherapy in the Treatment of Middle and Advanced Non-Small Cell Lung Cancer

Three-dimensional Conformal Radiotherapy Synchronized with Chemotherapy for Patients with Locally Advanced Non-small Cell Lung Cancer

Clinical study of pemetrexed combined with carboplatin as the first-line treatment of senile patients with advanced non-squamous non-small cell lung cancer

Comparative Analysis of Therapeutic Effect and Safety of Locally Advanced Non-Small Cell Lung Cancer in the Elderly by Sequential and Concurrent Chemoradiotherapy

Observation on Curative Effects of Concurrent Radiotherapy and Chemotherapy for Advanced Non-small-cell Lung Cancer

Research of three-dimensional conformal radiotherapy combined with concurrent weekly oxaliplatin for inoperable stage Ⅲ non-small cell lung cancer

Concomitant Pemetrexed/carboplatin Chemotherapy and 3D Conformal Radiotherapy Followed by Pemetrexed/carboplatin Consolidation Chemotherapy for Locally Advanced Non-Small Cell Lung Cancer: Preliminary Results of a Phase II Study.